Novamind Inc.: Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

• Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory• Shared mission of responsibly

Related Keywords

United States ,Canada ,University Of Utah ,Utah ,Toronto ,Ontario ,Vancouver ,British Columbia ,America ,Canadian ,American ,Payton Nyquvest ,Jamie Kokoska ,Numinus Bioscience ,Samantha Delenardo ,Yaron Conforti ,Instagram ,Linkedin ,Twitter ,Cozen Oconnor ,Public Benefit Corporation ,Novamind Special Committee ,Facebook ,Canadian Securities Exchange ,Numinus Wellness Inc ,Research Leadership ,Novamind Inc ,Investor Relations Communications ,Novamind Board The Special Committee ,Numinus The Exchange Ratio ,Health Canada Controlled Drugs Substances ,Toronto Stock Exchange ,Usona Institute ,North American ,Benefit Corporation ,Numinus Wellness ,North America ,Novamind Shareholders ,Health Canada Controlled Drugs ,Substances License ,Mindfulness Oriented Recovery Enhancement ,Forma Financial Information ,Eight Capital ,Directors Recommendation ,Novamind Shares ,Novamind Board ,Numinu Investor Relations ,Toll Free North America ,Investor Relations ,Novamind ,Lluminus ,Cquire ,Reating ,North ,Industry ,Leader ,Sychedelic ,Therapy ,Research ,